MedTrace Logo

Psychiatry of Transition in a World in Transition

NCT04333797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 252

Last updated 2026-01-07

No results posted yet for this study

Summary

This clinical study evaluates risk and protective factor to develop psychopathology in transitional age youth. 300 patients will be recruited at the age of 17 years old and assessed at baseline and 2 years later.

Conditions

Interventions

OTHER

Risk and Protective Factors Assessment

First assessment at baseline (T0) - 17 y.o. Follow-up 2 years later (T1) - 19 y.o.

Sponsors & Collaborators

  • Erasme University Hospital

    collaborator OTHER

  • Brugmann University Hospital

    collaborator OTHER

  • Service santé mentale à l'ULB

    collaborator UNKNOWN

  • Université Libre de Bruxelles

    collaborator OTHER

  • King Baudouin Foundation

    collaborator OTHER

  • Queen Fabiola Children's University Hospital

    lead OTHER

Principal Investigators

  • Véronique Delvenne, MD, PhD · Queen Fabiola Children's University Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
17 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-10
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04333797 on ClinicalTrials.gov